Coya Therapeutics Receives $4.2 Million Milestone Payment for ALS Trial Initiation
I'm PortAI, I can summarize articles.
Coya Therapeutics Inc. received a $4.2 million milestone payment from Dr. Reddy’s Laboratories for initiating the ALSTARS trial of COYA 302 for ALS treatment. The payment was triggered by dosing the first patient in the trial. This information was published by Coya Therapeutics via EDGAR on December 17, 2025.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments